NL-OMON36158已完成不适用
A randomised, double-blind, placebo-controlled, cross-over study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending oral doses of GSK2239633 in healthy male subjects. - GSK2239633 SAD study
PRA International EDS0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •18-65 years of age
- •BMI 18.5 - 29.9 kg/m2 (inclusive) and body weight >50 kg
排除标准
- •Positive pre-study Hepatitis B, Hepatitis C, HIV
- •Diagnosed as not-healthy
研究者
相似试验
已完成
不适用
Preventing Nerve Damage Induced by ChemotherapyColorectal cancerPeripheral neuropathyACTRN12611000738921Dr Mark McKeage12
已完成
3 期
A randomised, double-blind, placebo-controlled, crossover trial investigating the effects of two nutraceutical combination formulas on mental fatigue, mood and neurocognitive performance in healthy adults.Mental fatigueCognitive functionSelf-rated moodCerebral blood flow and oxygen metabolismBrain biochemistryDiet and Nutrition - Other diet and nutrition disordersMental Health - Studies of normal psychology, cognitive function and behaviourNeurological - Studies of the normal brain and nervous systemACTRN12615000062527Swinburne University of Technology30
已完成
不适用
A randomised, double-blind, placebo-controlled, cross-over pilot study using nabilone for symptomatic relief in patients with Huntington's diseaseHuntington's diseaseNervous System DiseasesISRCTN16782845Birmingham and Solihull Mental Health Trust (UK)
招募中
2 期
Effects of cannabidiol (CBD) on chronic pain following spinal cord injurySpinal cord injuryACTRN12622000634774niversity of Sydney40
进行中（未招募）
1 期
Precision medicine with zibotentan in microvascular angina (PRIZE)Microvascular Angina and impaired exercise intolerance.MedDRA version: 20.0Level: LLTClassification code 10065566Term: Microvascular anginaSystem Organ Class: 100000004849EUCTR2018-004393-10-GBHS Greater Glasgow & Clyde356